SCPH
scPharmaceuticals
SCPH
SCPH
Delisted
SCPH was delisted on the 6th of October, 2025.
46 hedge funds and large institutions have $114M invested in scPharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 17 increasing their positions, 14 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
46
Holders Change
-1
Holders Change %
-2.13%
% of All Funds
0.81%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
17
Reduced
14
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Goldman Sachs
New York
|
+$4.05M |
| 2 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$1.45M |
| 3 |
JGC
J. Goldman & Co
New York
|
+$1.32M |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$763K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$683K |
Top Sellers
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$5.24M |
| 2 |
IC
Ikarian Capital
Dallas,
Texas
|
-$1.05M |
| 3 |
Renaissance Technologies
New York
|
-$370K |
| 4 |
ZIM
Zacks Investment Management
Chicago,
Illinois
|
-$204K |
| 5 |
VF
Virtu Financial
New York
|
-$192K |
